Scarica l'app Stockscreener
2.24
2.61%
-0.06
Dopo l'orario di chiusura:
2.26
0.02
+0.89%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Veru Inc Borsa (VERU) Ultime notizie
Veru outlines new Phase IIb obesity trial and targets interim analysis in Q1 2027 while increasing cash reserves - MSN
Veru Inc. (NASDAQ: VERU) Q1 2026 earnings call transcript - MSN
Veru Inc. (NASDAQ:VERU) Q1 2026 Earnings Call Transcript - Insider Monkey
Veru Q1 2026 Earnings Call Transcript - MarketBeat
Veru Inc. Charts Risky but Clearer Post-GLP-1 Path - TipRanks
Veru Inc (VERU) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges By GuruFocus - Investing.com Canada
Veru Inc. (VERU) Advances Clinical Pipeline with Enobosarm and S - GuruFocus
Veru Inc (VERU) Q1 2026 Earnings Call Highlights: Strategic Adva - GuruFocus
VERU INC. SEC 10-Q Report - TradingView
VERU: No revenue, $5.3M net loss, $33M cash, strategic shift to drug development, going concern risk - TradingView
Veru (VERU) Q1 2026 Earnings Call Transcript - The Globe and Mail
VERU: Net loss narrowed, cash reserves rose, and enobosarm advances with FDA support for new trials - TradingView
Earnings call transcript: Veru Inc. Q1 2026 sees stock rise amid strategic shifts - Investing.com
Earnings call transcript: Veru Inc. Q1 2026 sees stock rise amid strategic shifts By Investing.com - Investing.com India
Veru reports Q1 EPS (26c) vs. (61c) last year - TipRanks
VERU INC (NASDAQ:VERU) Reports Narrower-Than-Expected Q1 Loss, Highlights Key Clinical Trial Timeline - ChartMill
Veru Inc. Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress - TradingView
VERU: Q1 net loss narrowed, cash rose, and new enobosarm/semaglutide trial to launch soon - TradingView
Veru (NASDAQ: VERU) narrows loss as enobosarm obesity program advances - Stock Titan
Veru Inc. Advances Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide for Weight Management in Older Adults with Obesity - Quiver Quantitative
Veru tests enobosarm to help older semaglutide users beat weight-loss plateau - Stock Titan
A Look at Veru's Upcoming Earnings Report - Benzinga
Veru Inc. (VERU.US) is scheduled to release its earnings report before the market opens on February 11. - 富途牛牛
Veru (VERU) Price Target Increased by 11.11% to 25.50 - Nasdaq
Veru Inc. to Host Conference Call for Fiscal 2026 First Quarter Financial Results and Business Update - Quiver Quantitative
Biopharma Veru sets Feb. 11 webcast on Q1 2026 results - Stock Titan
Published on: 2026-02-01 18:16:35 - baoquankhu1.vn
Wall Street Recap: Is Veru Inc a defensive stockJuly 2025 PostEarnings & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Block Trades: Will Veru Inc benefit from AI trends2025 Major Catalysts & Intraday High Probability Setup Alerts - baoquankhu1.vn
Analyzing Verano (OTCMKTS:VRNOF) & Veru (NASDAQ:VERU) - Defense World
Growth Report: Will Veru Inc benefit from AI trends2025 Buyback Activity & Fast Momentum Entry Tips - baoquankhu1.vn
Veru prices 1.4M shares at $3.00 in underwritten public offering - MSN
Targets Report: Will Veru Inc stock attract ESG investors2025 Market Sentiment & Real-Time Volume Analysis - Bộ Nội Vụ
What Investors Should Know About a $1.5 Million Apogee Insider Sale Amid a 60% Stock Rally - AOL.com
Is Veru Inc. stock a buy in volatile marketsJuly 2025 Final Week & Trade Opportunity Analysis - Улправда
Why Veru Inc. (FMW) stock trades below fair valueTrade Entry Report & Fast Entry High Yield Tips - ulpravda.ru
Is Veru Inc. stock attractive after correction2025 Macro Impact & Entry Point Confirmation Alerts - ulpravda.ru
ulpravda> 2026> How dovish Fed policy supports Veru Inc. (FMW) stockTake Profit & High Conviction Buy Zone Picks - ulpravda.ru
Why Veru Inc. (FMW) stock remains stableProfit Target & Low Risk High Reward Ideas - Улправда
Aug Drivers: Why Veru Inc. (FMW) stock remains stable2025 Stock Rankings & Risk Controlled Stock Alerts - ulpravda.ru
About UsGreat American Insurance GroupSpecialty Property & Casualty Insurance - FinancialContent
Veru Inc.Common Stock (NQ: VERU - FinancialContent
Why Vera Therapeutics Stock Zoomed Higher Today - AOL.com
Is Veru Inc. (FMW) stock prepared for digital transitionWeekly Market Report & Daily Entry Point Trade Alerts - ulpravda.ru
User | poteaudailynews.comVeru Inc.Common Stock (Nasdaq:VERU) Stock Quote - FinancialContent
What Makes Veru Inc. (VERU) a Strong Momentum Stock: Buy Now? - MSN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Veru (NASDAQ:VERU) Share Price Crosses Below Two Hundred Day Moving Average – What’s Next? - Defense World
Veru outlines 72-week Phase IIb PLATEAU study targeting obesity plateau population following FDA guidance - MSN
Veru Inc | 4: Statement of changes in beneficial ownership of securities-Director Hyun Grace - 富途牛牛
Veru Inc. (NASDAQ:VERU) Q4 2025 Earnings Call Transcript - Insider Monkey
Market Review: Can Veru Inc stock maintain growth trajectoryJuly 2025 Short Interest & Trade Opportunity Analysis Reports - moha.gov.vn
Veru Inc. Earnings Call: Lean Mass Wins, Losses Mount - TipRanks
Will Veru Inc. stock outperform Nasdaq indexPortfolio Value Summary & Free Real-Time Market Sentiment Alerts - Улправда
MACD Signal: Why Veru Inc. stock remains resilientTrade Entry Summary & Short-Term High Return Ideas - moha.gov.vn
Veru Inc. (NASDAQ:VERU) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Will Veru Inc. (FMW) stock profit from fiscal stimulusDividend Hike & Accurate Trade Setup Notifications - Улправда
How Veru Inc. stock reacts to oil pricesMarket Sentiment Summary & Daily Stock Trend Reports - Улправда
Will Veru Inc. stock continue dividend increasesMarket Risk Report & Technical Confirmation Alerts - Улправда
Canaccord Genuity Initiates Coverage of Veru (VERU) with Buy Recommendation - Nasdaq
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):